Editorial overview: Biomarkers: The pièce de résistance of innovative medicines

Current Opinion in Drug Discovery and Development

Volumn 10, Issue 1, 2007, Pages 22-24

  Johnson, Dale E ^a,b   Smith, Dennis A ^c   Park, B Kevin ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Emiliem Inc   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL;

CLINICAL RESEARCH; DIAGNOSTIC TEST; DRUG PROGRAM; DRUG SCREENING; EDITORIAL; HEALTH CARE; HEALTH CARE SYSTEM; HUMAN; INDIVIDUALITY; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL RESEARCH; PUBLIC HEALTH SERVICE; BLOOD; CARDIOVASCULAR DISEASE; CLINICAL PATHWAY; FOOD AND DRUG ADMINISTRATION; METHODOLOGY; RISK FACTOR; UNITED STATES;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CRITICAL PATHWAYS; DIAGNOSTIC TESTS, ROUTINE; HUMANS; RISK FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33947313317     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (0)